Collagen as a Biomarker for Spine Degeneration

Intervertebral disc (IVD) degeneration is a leading contributor to low back pain and spinal disorders, yet current diagnostic approaches often fail to detect early molecular changes. Collagen, the primary structural protein of the disc, undergoes degradation long before visible structural damage occurs. This makes collagen damage a powerful and underutilized biomarker for assessing spine health. By focusing on collagen dynamics, researchers can uncover early degenerative processes, enabling more accurate diagnoses and targeted interventions.

How CHPs Transform Spinal Degeneration Research

CHPs are advanced tools to uncover, measure, and understand the complexities of collagen dynamics, revolutionizing IVD degeneration research.

Detecting Early Molecular Damage

CHPs enable the identification of collagen denaturation at the molecular level, allowing researchers to detect early-stage IVD degeneration long before structural changes are visible.

Mapping Collagen Damage

CHPs precisely localize areas of collagen damage, providing researchers with detailed insights into the spatial patterns of degeneration within the intervertebral disc.

Enabling Longitudinal Studies

With non-invasive applications, CHPs allow researchers to track collagen changes over time in experimental models, supporting dynamic and longitudinal research.

Supporting Therapeutic Evaluation

CHPs provide measurable data on collagen remodeling, enabling researchers to assess the efficacy of new treatments aimed at mitigating IVD degeneration.